FDA Issues Guidance On Development Of Coronavirus Vaccines

Pulmonology Advisor (7/7, Ernst) reports the FDA “issued guidance to assist in the development and licensure of” SARS-CoV-2 vaccines. The guidance includes “recommendations for satisfying regulatory requirements for approval, including nonclinical and cli...